Propafenone HCl
CAS: 34183-22-7
Rif. 3D-FP27186
10g | 144,00 € | ||
25g | 217,00 € | ||
50g | 325,00 € | ||
100g | 452,00 € | ||
250g | 863,00 € |
Informazioni sul prodotto
- 1-[2-[2-Hydroxy-3-(propylamino)propoxy]phenyl]-3-phenyl-1-propanone hydrochloride2'-[2-Hydroxy-3-(propylamino)propoxy]-3-phenylprop iophenone hydrochlorideArythmol
- 1-(2-(2-Hydroxy-3-(propylamino)propoxy)phenyl)-3-phenylpropan-1-one hydrochloride
- 1-Propanone, 1-(2-(2-hydroxy-3-(propylamino)propoxy)phenyl)-3-phenyl-, hydrochloride
- 1-Propanone, 1-[2-[2-hydroxy-3-(propylamino)propoxy]phenyl]-3-phenyl-, hydrochloride (1:1)
- 1-{2-[2-Hydroxy-3-(Propylamino)Propoxy]Phenyl}-3-Phenylpropan-1-One Hydrochloride (1:1)
- 2'-(2-Hydroxy-3-(propylamino)propoxy)-3-phenylpropiophenone hydrochloride
- Arythmol
- Baxarytmon
- Fenoprain
- Pronon
- Vedi altri sinonimi
- Propafenon hydrochlorid
- Propafenon hydrochlorid [German]
- Propafenone hydrochloride
- Propafenone hydrochloride [USAN:JAN]
- Propiophenone, 2'-(2-hydroxy-3-(propylamino)propoxy)-3-phenyl-, hydrochloride
- Rhythmonorm
- Rythmol
- Rythmol SR
- Rytmonorm
- Sa 79
- Unii-33Xch0Hocd
- Wz 884
Propafenone HCl is a class Ia antiarrhythmic drug that is used to treat atrial fibrillation and other cardiac arrhythmias. It has a high solubility in water, which makes it suitable for intravenous administration. The binding constants of propafenone to the cardiac muscle and myocardial cells are relatively high. This drug has also been shown to be safe in pediatric patients with congestive heart failure. Propafenone HCl has been shown to have an adverse effect on some people, causing serious side effects such as congestive heart failure or hypersensitivity reactions.
Proprietà chimiche
Richiesta tecnica su: 3D-FP27186 Propafenone HCl
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.